Ludmila Sidorenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ludmila Sidorenko has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Niels Wessel
Department of Physics, Humboldt-Universität zu Berlin, Berlin, Germany
4 shared publications - Attia Guy
Nicolae Testemitsanu State University of Medicine and Pharmacy Stefan cel Mare str. 165 Chisinau
3 shared publications - Erez Arad
Nicolae Testemitsanu State University of Medicine and Pharmacy Chisinau the Republic of Moldova
3 shared publications - Ilan Davidov
Nicolae Testemitsanu State University of Medicine and Pharmacy Chisinau the Republic of Moldova
3 shared publications - R. M. Chornopyshchuk
Вінницький національний медичний університет імені М.І. Пирогова
3 shared publications - Anatolie Sidorenko
Technical University of Moldova
2 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Kharkiv National University of Radioelectronics in Innovative technologies and scientific solutions for industries
- No. 1(35),p. 55-64
Predicting Risks of Cardiovascular Disease on Small Datasets using Feature Engineering
Relevance. Cardiovascular diseases remain a leading cause of mortality globally, creating a high demand for automated diagnostic systems. However, developing reliable machine learning models for electrocardiogram (ECG) analysis is often hindered by the availability of only small-scale and imbalanced datasets, which limits the effectiveness of deep learning approaches. The object of research is the process of automated processing and classification of electrocardiographic signals for diagnostic purposes. The subject of the research includes methods of beat-centric feature extraction, patient-level aggregation strategies, and machine learning algorithms for cardiovascular risk prediction. The purpose of this paper is to develop and evaluate a reliable classification framework, optimized for small datasets, that increases prediction accuracy by leveraging patient-level feature aggregation and explainable machine learning models. To achieve this goal, the following tasks were solved: 1) implementation of a robust preprocessing pipeline using a refined Pan-Tompkins algorithm for precise beat-centric segmentation; 2) development of a statistical feature aggregation strategy to mitigate local signal variability; and 3) optimization and validation of a Random Forest classifier. The methodology employed includes digital signal processing (Butterworth filtering), advanced feature engineering (HRV, Wavelets analysis), and rigorous 10-fold Stratified Cross-Validation to ensure generalization on limited data. Research results. The study proposes a pipeline initiating with standard signal preprocessing, followed by precise R-peak detection and beat-centric segmentation. Physiological features (HRV, wavelet, morphological) are then extracted from individual segments and statistically aggregated at the patient level. Experiments on a dataset of 164 subjects demonstrated that the proposed patient-level aggregation strategy significantly outperformed traditional segment-based analysis. The final Random Forest model achieved an ROC-AUC score of 0.84. Feature importance analysis confirmed the critical role of Heart Rate Variability (HRV) metrics, particularly SDNN and RMSSD, in differentiating between healthy and high-risk subjects.
- 30 March 2026
- Published by Kharkiv National University of Radioelectronics in Innovative technologies and scientific solutions for industries
- No. 1(35),p. 55-64
Open AccessPredicting Risks of Cardiovascular Disease on Small Datasets using Feature Engineering
Relevance. Cardiovascular diseases remain a leading cause of mortality globally, creating a high demand for automated diagnostic systems. However, developing reliable machine learning models for electrocardiogram (ECG) analysis is often hindered by the availability of only small-scale and imbalanced datasets, which limits the effectiveness of deep learning approaches. The object of research is the process of automated processing and classification of electrocardiographic signals for diagnostic purposes. The subject of the research includes methods of beat-centric feature extraction, patient-level aggregation strategies, and machine learning algorithms for cardiovascular risk prediction. The purpose of this paper is to develop and evaluate a reliable classification framework, optimized for small datasets, that increases prediction accuracy by leveraging patient-level feature aggregation and explainable machine learning models. To achieve this goal, the following tasks were solved: 1) implementation of a robust preprocessing pipeline using a refined Pan-Tompkins algorithm for precise beat-centric segmentation; 2) development of a statistical feature aggregation strategy to mitigate local signal variability; and 3) optimization and validation of a Random Forest classifier. The methodology employed includes digital signal processing (Butterworth filtering), advanced feature engineering (HRV, Wavelets analysis), and rigorous 10-fold Stratified Cross-Validation to ensure generalization on limited data. Research results. The study proposes a pipeline initiating with standard signal preprocessing, followed by precise R-peak detection and beat-centric segmentation. Physiological features (HRV, wavelet, morphological) are then extracted from individual segments and statistically aggregated at the patient level. Experiments on a dataset of 164 subjects demonstrated that the proposed patient-level aggregation strategy significantly outperformed traditional segment-based analysis. The final Random Forest model achieved an ROC-AUC score of 0.84. Feature importance analysis confirmed the critical role of Heart Rate Variability (HRV) metrics, particularly SDNN and RMSSD, in differentiating between healthy and high-risk subjects.
- 1 October 2025
- Published by Springer Nature
- p. 322-330
Superconducting Components for Brain-Inspired Neural Networks: Spintronic Innovations for Neuromorphic Computing
- 1 October 2025
- Published by Springer Nature
- p. 322-330
Superconducting Components for Brain-Inspired Neural Networks: Spintronic Innovations for Neuromorphic Computing
- Open Access
- 14 March 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (6) , 3152
A Study of Immunoenzymatic Parameters in Pediatric Ischemic Stroke as a Contribution to More Efficient Pediatric Monitoring and Diagnosis
Introduction: Pediatric ischemic stroke (IS) is a rare but severe neurological emergency, with an incidence of 2–13 per 100,000. Most cases occur in the prenatal period or early infancy. Integrating artificial intelligence (AI) into clinical practice may enhance the early recognition of stroke. This pilot study aimed to identify immunoenzymatic markers as early predictors of pediatric IS, supporting machine learning applications. Materials and Methods: A prospective study (2017–2019) in Moldova included 53 children with IS and 53 healthy controls. The serum levels of vascular endothelial growth factor (VEGF), ciliary neurotrophic factor (CNTF), the S100B protein, CD105 (endoglin), antiphospholipid antibodies (APAs), and interleukin-6 (IL-6) were measured using ELISA during the acute phase. Results: Endoglin levels were significantly lower in IS patients (2.06 ± 0.012 ng/mL) vs. controls (2.51 ± 0.071 ng/mL) (p < 0.001). S100B levels were elevated (0.524 ± 0.0850 ng/mL vs. 0.120 ± 0.0038 ng/mL, p < 0.01). VEGF levels were significantly increased (613.41 ± 39.299 pg/mL vs. 185.50 ± 12.039 pg/mL, p < 0.001), correlating with the infarct size and disease severity. CNTF levels were also higher (7.84 ± 0.322 pg/mL vs. 5.29 ± 0.067 pg/mL, p < 0.001). APA levels were elevated (1.37 ± 0.046 U/mL vs. 0.92 ± 0.021 U/mL, p < 0.001). IL-6 levels were 10 times higher in IS patients (22.02 ± 2.143 pg/mL vs. 2.38 ± 0.302 pg/mL, p < 0.001), correlating with the infarct size (p < 0.004) and neurological prognosis at six months (p < 0.01). Conclusions: IL-6, VEGF, CNTF, S100B, CD105, and APAs are key markers in pediatric IS, reflecting neuroinflammation, vascular disruption, and the long-term prognosis. Their integration into AI-driven diagnostic models may improve early stroke detection and pediatric monitoring.
- 14 March 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (6) , 3152
Open AccessA Study of Immunoenzymatic Parameters in Pediatric Ischemic Stroke as a Contribution to More Efficient Pediatric Monitoring and Diagnosis
Introduction: Pediatric ischemic stroke (IS) is a rare but severe neurological emergency, with an incidence of 2–13 per 100,000. Most cases occur in the prenatal period or early infancy. Integrating artificial intelligence (AI) into clinical practice may enhance the early recognition of stroke. This pilot study aimed to identify immunoenzymatic markers as early predictors of pediatric IS, supporting machine learning applications. Materials and Methods: A prospective study (2017–2019) in Moldova included 53 children with IS and 53 healthy controls. The serum levels of vascular endothelial growth factor (VEGF), ciliary neurotrophic factor (CNTF), the S100B protein, CD105 (endoglin), antiphospholipid antibodies (APAs), and interleukin-6 (IL-6) were measured using ELISA during the acute phase. Results: Endoglin levels were significantly lower in IS patients (2.06 ± 0.012 ng/mL) vs. controls (2.51 ± 0.071 ng/mL) (p < 0.001). S100B levels were elevated (0.524 ± 0.0850 ng/mL vs. 0.120 ± 0.0038 ng/mL, p < 0.01). VEGF levels were significantly increased (613.41 ± 39.299 pg/mL vs. 185.50 ± 12.039 pg/mL, p < 0.001), correlating with the infarct size and disease severity. CNTF levels were also higher (7.84 ± 0.322 pg/mL vs. 5.29 ± 0.067 pg/mL, p < 0.001). APA levels were elevated (1.37 ± 0.046 U/mL vs. 0.92 ± 0.021 U/mL, p < 0.001). IL-6 levels were 10 times higher in IS patients (22.02 ± 2.143 pg/mL vs. 2.38 ± 0.302 pg/mL, p < 0.001), correlating with the infarct size (p < 0.004) and neurological prognosis at six months (p < 0.01). Conclusions: IL-6, VEGF, CNTF, S100B, CD105, and APAs are key markers in pediatric IS, reflecting neuroinflammation, vascular disruption, and the long-term prognosis. Their integration into AI-driven diagnostic models may improve early stroke detection and pediatric monitoring.
- Open Access
- 22 April 2024
- Published by MDPI AG in Algorithms
- Vol. 17 (4) , 171
Pediatric Ischemic Stroke: Clinical and Paraclinical Manifestations—Algorithms for Diagnosis and Treatment
Childhood stroke can lead to lifelong disability. Developing algorithms for timely recognition of clinical and paraclinical signs is crucial to ensure prompt stroke diagnosis and minimize decision-making time. This study aimed to characterize clinical and paraclinical symptoms of childhood and neonatal stroke as relevant diagnostic criteria encountered in clinical practice, in order to develop algorithms for prompt stroke diagnosis. The analysis included data from 402 pediatric case histories from 2010 to 2016 and 108 prospective stroke cases from 2017 to 2020. Stroke cases were predominantly diagnosed in newborns, with 362 (71%, 95% CI 68.99–73.01) cases occurring within the first 28 days of birth, and 148 (29%, 95% CI 26.99–31.01) cases occurring after 28 days. The findings of the study enable the development of algorithms for timely stroke recognition, facilitating the selection of optimal treatment options for newborns and children of various age groups. Logistic regression serves as the basis for deriving these algorithms, aiming to initiate early treatment and reduce lifelong morbidity and mortality in children. The study outcomes include the formulation of algorithms for timely recognition of newborn stroke, with plans to adopt these algorithms and train a fuzzy classifier-based diagnostic model using machine learning techniques for efficient stroke recognition.
- 22 April 2024
- Published by MDPI AG in Algorithms
- Vol. 17 (4) , 171
Open AccessPediatric Ischemic Stroke: Clinical and Paraclinical Manifestations—Algorithms for Diagnosis and Treatment
Childhood stroke can lead to lifelong disability. Developing algorithms for timely recognition of clinical and paraclinical signs is crucial to ensure prompt stroke diagnosis and minimize decision-making time. This study aimed to characterize clinical and paraclinical symptoms of childhood and neonatal stroke as relevant diagnostic criteria encountered in clinical practice, in order to develop algorithms for prompt stroke diagnosis. The analysis included data from 402 pediatric case histories from 2010 to 2016 and 108 prospective stroke cases from 2017 to 2020. Stroke cases were predominantly diagnosed in newborns, with 362 (71%, 95% CI 68.99–73.01) cases occurring within the first 28 days of birth, and 148 (29%, 95% CI 26.99–31.01) cases occurring after 28 days. The findings of the study enable the development of algorithms for timely stroke recognition, facilitating the selection of optimal treatment options for newborns and children of various age groups. Logistic regression serves as the basis for deriving these algorithms, aiming to initiate early treatment and reduce lifelong morbidity and mortality in children. The study outcomes include the formulation of algorithms for timely recognition of newborn stroke, with plans to adopt these algorithms and train a fuzzy classifier-based diagnostic model using machine learning techniques for efficient stroke recognition.
- 14 September 2023
- Published by Springer Nature
- p. 421-430
Hemodynamic Protective Assessment of BurnNavi-Guided Fluid Management in Burned Patients: Pilot Study
- 14 September 2023
- Published by Springer Nature
- p. 421-430
Hemodynamic Protective Assessment of BurnNavi-Guided Fluid Management in Burned Patients: Pilot Study
- 12 September 2023
- Published by Springer Nature
- p. 564-573
Neural Circuits-Adjusted Diagnostic Approach to Predict Recurrence of Atrial Fibrillation
- 12 September 2023
- Published by Springer Nature
- p. 564-573
Neural Circuits-Adjusted Diagnostic Approach to Predict Recurrence of Atrial Fibrillation
- Open Access
Pathological Heart Rate Regulation in Apparently Healthy Individuals
Cardiovascular diseases are the leading cause of morbidity and mortality in adults worldwide. There is one common pathophysiological aspect present in all cardiovascular diseases—dysfunctional heart rhythm regulation. Taking this aspect into consideration for cardiovascular risk predictions opens important research perspectives, allowing for the development of preventive treatment techniques. The aim of this study was to find out whether certain pathologically appearing signs in the heart rate variability (HRV) of an apparently healthy person, even with high HRV, can be defined as biomarkers for a disturbed cardiac regulation and whether this can be treated preventively by a drug-free method. This multi-phase study included 218 healthy subjects of either sex, who consecutively visited the physician at Gesundheit clinic because of arterial hypertension, depression, headache, psycho-emotional stress, extreme weakness, disturbed night sleep, heart palpitations, or chest pain. In study phase A, baseline measurement to identify individuals with cardiovascular risks was done. Therefore, standard HRV, as well as the new cardiorhythmogram (CRG) method, were applied to all subjects. The new CRG analysis used here is based on the recently introduced LF drops and HF counter-regulation. Regarding the mechanisms of why these appear in a steady-state cardiorhythmmogram, they represent non-linear event-based dynamical HRV biomarkers. The next phase of the study, phase B, tested whether the pathologically appearing signs identified via CRG in phase A could be clinically influenced by drug-free treatment. In order to validate the new CRG method, it was supported by non-linear HRV analysis in both phase A and in phase B. Out of 218 subjects, the pathologically appearing signs could be detected in 130 cases (60%), p < 0.01, by the new CRG method, and by the standard HRV analysis in 40 cases (18%), p < 0.05. Thus, the CRG method was able to detect 42% more cases with pathologically appearing cardiac regulation. In addition, the comparative CRG analysis before and after treatment showed that the pathologically appearing signs could be clinically influenced without the use of medication. After treatment, the risk group decreased eight-fold—from 130 people to 16 (p < 0.01). Therefore, progression of the detected pathological signs to structural cardiac pathology or arrhythmia could be prevented in most of the cases. However, in the remaining risk group of 16 apparently healthy subjects, 8 people died due to all-cause mortality. In contrast, no other subject in this study has died so far. The non-linear parameter which is able to quantify the changes in CRGs before versus after treatment is FWRENYI4 (symbolic dynamic feature); it decreased from 2.85 to 2.53 (p < 0.001). In summary, signs of pathological cardiac regulation can be identified by the CRG analysis of apparently healthy subjects in the early stages of development of cardiac pathology. Thus, our method offers a sensitive biomarker for cardiovascular risks. The latter can be influenced by non-drug treatments (acupuncture) to stop the progression into structural cardiac pathologies or arrhythmias in most but not all of the patients. Therefore, this could be a real and easy-to-use supplemental method, contributing to primary prevention in cardiology.
Open AccessPathological Heart Rate Regulation in Apparently Healthy Individuals
Cardiovascular diseases are the leading cause of morbidity and mortality in adults worldwide. There is one common pathophysiological aspect present in all cardiovascular diseases—dysfunctional heart rhythm regulation. Taking this aspect into consideration for cardiovascular risk predictions opens important research perspectives, allowing for the development of preventive treatment techniques. The aim of this study was to find out whether certain pathologically appearing signs in the heart rate variability (HRV) of an apparently healthy person, even with high HRV, can be defined as biomarkers for a disturbed cardiac regulation and whether this can be treated preventively by a drug-free method. This multi-phase study included 218 healthy subjects of either sex, who consecutively visited the physician at Gesundheit clinic because of arterial hypertension, depression, headache, psycho-emotional stress, extreme weakness, disturbed night sleep, heart palpitations, or chest pain. In study phase A, baseline measurement to identify individuals with cardiovascular risks was done. Therefore, standard HRV, as well as the new cardiorhythmogram (CRG) method, were applied to all subjects. The new CRG analysis used here is based on the recently introduced LF drops and HF counter-regulation. Regarding the mechanisms of why these appear in a steady-state cardiorhythmmogram, they represent non-linear event-based dynamical HRV biomarkers. The next phase of the study, phase B, tested whether the pathologically appearing signs identified via CRG in phase A could be clinically influenced by drug-free treatment. In order to validate the new CRG method, it was supported by non-linear HRV analysis in both phase A and in phase B. Out of 218 subjects, the pathologically appearing signs could be detected in 130 cases (60%), p < 0.01, by the new CRG method, and by the standard HRV analysis in 40 cases (18%), p < 0.05. Thus, the CRG method was able to detect 42% more cases with pathologically appearing cardiac regulation. In addition, the comparative CRG analysis before and after treatment showed that the pathologically appearing signs could be clinically influenced without the use of medication. After treatment, the risk group decreased eight-fold—from 130 people to 16 (p < 0.01). Therefore, progression of the detected pathological signs to structural cardiac pathology or arrhythmia could be prevented in most of the cases. However, in the remaining risk group of 16 apparently healthy subjects, 8 people died due to all-cause mortality. In contrast, no other subject in this study has died so far. The non-linear parameter which is able to quantify the changes in CRGs before versus after treatment is FWRENYI4 (symbolic dynamic feature); it decreased from 2.85 to 2.53 (p < 0.001). In summary, signs of pathological cardiac regulation can be identified by the CRG analysis of apparently healthy subjects in the early stages of development of cardiac pathology. Thus, our method offers a sensitive biomarker for cardiovascular risks. The latter can be influenced by non-drug treatments (acupuncture) to stop the progression into structural cardiac pathologies or arrhythmias in most but not all of the patients. Therefore, this could be a real and easy-to-use supplemental method, contributing to primary prevention in cardiology.
- Open Access
- 1 December 2022
- Published by Technical University of Moldova
- p. 41-45
New Biophysical Approach in Analysis of Heart Rate Variability for Increasing its Predictive Value
Background. Regarding the high incidence of cardiovascular diseases, it is critical to find predictors. The aim of this study is to appreciate the predivtive value of of recently-found parameters of cardiorhythmogram analysis applying the new biophysical approach for predicting the recurrence of atrial fibrillation. Material and methods. This is a case-series study, where 350 cardiorhythmograms were assessed. For assessment both methods were applied, the standard heart rate variability analysis and new approach by the parameters HF counterregulation and LF drops. Results. The both newly-found parameters predict reliably atrial fibrillation recurrence. The significance of the parameter HF counterregulation is p < 0.0001, in case of the parameter LF drops it is p < 0.001. Conclusions. In case if prediction is needed, the standard heart rate variability should be completed by the new biophysical approach, applying the parameters HF counterregulation and LF drops. Steady-state cardiorhythmograms with events of unstationarity can be realiably analysed just by these parameters. Events of unstationarity are informative sources for prediction.
- 1 December 2022
- Published by Technical University of Moldova
- p. 41-45
Open AccessNew Biophysical Approach in Analysis of Heart Rate Variability for Increasing its Predictive Value
Background. Regarding the high incidence of cardiovascular diseases, it is critical to find predictors. The aim of this study is to appreciate the predivtive value of of recently-found parameters of cardiorhythmogram analysis applying the new biophysical approach for predicting the recurrence of atrial fibrillation. Material and methods. This is a case-series study, where 350 cardiorhythmograms were assessed. For assessment both methods were applied, the standard heart rate variability analysis and new approach by the parameters HF counterregulation and LF drops. Results. The both newly-found parameters predict reliably atrial fibrillation recurrence. The significance of the parameter HF counterregulation is p < 0.0001, in case of the parameter LF drops it is p < 0.001. Conclusions. In case if prediction is needed, the standard heart rate variability should be completed by the new biophysical approach, applying the parameters HF counterregulation and LF drops. Steady-state cardiorhythmograms with events of unstationarity can be realiably analysed just by these parameters. Events of unstationarity are informative sources for prediction.
- Open Access
- 1 December 2022
- Published by Technical University of Moldova
- p. 55-58
Recent Biotechnological Approach to Genetically Determined Atrial Fibrillation
The most prevalent persistent arrhythmia in cardiology is atrial fibrillation. Former atrial fibrillation which appears without any underlying reason was called „lone atrial fibrillation“. Due to new biotechnological methods in electrophysiology, like mapping, unusual conducting mechanisms were stabilized. Due to new biotechnological methods of DNA analysis recently the reason is detected. This is a genetically determined atrial fibrillation. The aim of this study is to analyse what are the most common mutations which lead to atrial fibrillation. Material and methods. This is a systematic review study. The sources of information which were analysed are mostly from google scholar and web of science. From 2000 sources, several sources were filtered out by the keywords and remained 14 sources on which is based this review study. Results. More than 70 genes are recently detected which lead to atrial fibrillations. Majority of them are mutations of the genes which encode the transport proteins of the heart’s conductive system. The most common mutations that lead to genetically determined atrial fibrillation occure in KCNQ1, KCNA5 and 6q14–16. Conclusions. Before starting treatment of lone atrial fibrillation, a genetical test should be done in order to stabilize the type of the underlying mutation. This is a tactical step in taking the decision on treatment strategy by antiarrhytmic drugs or ablation. So ablatogenoics is the best solution for patients with genetically determined atrial fibrillation.
- 1 December 2022
- Published by Technical University of Moldova
- p. 55-58
Open AccessRecent Biotechnological Approach to Genetically Determined Atrial Fibrillation
The most prevalent persistent arrhythmia in cardiology is atrial fibrillation. Former atrial fibrillation which appears without any underlying reason was called „lone atrial fibrillation“. Due to new biotechnological methods in electrophysiology, like mapping, unusual conducting mechanisms were stabilized. Due to new biotechnological methods of DNA analysis recently the reason is detected. This is a genetically determined atrial fibrillation. The aim of this study is to analyse what are the most common mutations which lead to atrial fibrillation. Material and methods. This is a systematic review study. The sources of information which were analysed are mostly from google scholar and web of science. From 2000 sources, several sources were filtered out by the keywords and remained 14 sources on which is based this review study. Results. More than 70 genes are recently detected which lead to atrial fibrillations. Majority of them are mutations of the genes which encode the transport proteins of the heart’s conductive system. The most common mutations that lead to genetically determined atrial fibrillation occure in KCNQ1, KCNA5 and 6q14–16. Conclusions. Before starting treatment of lone atrial fibrillation, a genetical test should be done in order to stabilize the type of the underlying mutation. This is a tactical step in taking the decision on treatment strategy by antiarrhytmic drugs or ablation. So ablatogenoics is the best solution for patients with genetically determined atrial fibrillation.
- Open Access
- 1 December 2022
- Published by Technical University of Moldova
- p. 46-49
New Biotechnological Opportunities to Assess the Influence of Lifestyle Factors in Obesity
Background. Obesity results from a malfunction of the body's weight-control mechanisms, which may be influenced by environmental changes. Essentially, the obesity risk relies on two significant interdependent factors: genetic variations (single-nucleotide polymorphisms, haplotypes) and environmental risk exposure. Due to new biotechnologies over 127 potential genes for obesity have been identified, and evidence supports the function of 22 genes in at least five distinct groups. Gene and environment interactions mean that the synergy between genotype and environment is neither additive or multiplicative. The application of innovative methods for both genotype and lifestyle variables should be emphasized. Aim of study: Investigate variable data of lifestyle factors in obese people with genetic predisposition and without in order to figure out the trigger risks which transform the predisposition into obesity. Material and methods: This is a descriptive study. A questionnaire was elaborated. It was developed based on the data of new biotechnological analysis of metabolic changes in obese humans. 142 individuals were included. 82 obese individuals, 42 with genetic predisposition and 40 without, and 60 healthy probands were interviewed. Further followed a comparative statistical analysis. Results: Obese probands were found with higher levels of disability compare those without, cardiovascular events higher compared with healthy probnads, disability level and smoking habits had significantly correlation in obese with genetic predisposition. On the other hand, health probands were found in higher level of anxiety compared obese people with genetic predisposition. Conclusions: All the lifestyle aspects which lead to an increased central nervous overactivity disturb significantly the metabolism and are critical risk factors for people with genetic predisposition relate to the pathogenesis of obesity. that might lead to high disability level associated comorbid states and high risk of cardiovascular events.
- 1 December 2022
- Published by Technical University of Moldova
- p. 46-49
Open AccessNew Biotechnological Opportunities to Assess the Influence of Lifestyle Factors in Obesity
Background. Obesity results from a malfunction of the body's weight-control mechanisms, which may be influenced by environmental changes. Essentially, the obesity risk relies on two significant interdependent factors: genetic variations (single-nucleotide polymorphisms, haplotypes) and environmental risk exposure. Due to new biotechnologies over 127 potential genes for obesity have been identified, and evidence supports the function of 22 genes in at least five distinct groups. Gene and environment interactions mean that the synergy between genotype and environment is neither additive or multiplicative. The application of innovative methods for both genotype and lifestyle variables should be emphasized. Aim of study: Investigate variable data of lifestyle factors in obese people with genetic predisposition and without in order to figure out the trigger risks which transform the predisposition into obesity. Material and methods: This is a descriptive study. A questionnaire was elaborated. It was developed based on the data of new biotechnological analysis of metabolic changes in obese humans. 142 individuals were included. 82 obese individuals, 42 with genetic predisposition and 40 without, and 60 healthy probands were interviewed. Further followed a comparative statistical analysis. Results: Obese probands were found with higher levels of disability compare those without, cardiovascular events higher compared with healthy probnads, disability level and smoking habits had significantly correlation in obese with genetic predisposition. On the other hand, health probands were found in higher level of anxiety compared obese people with genetic predisposition. Conclusions: All the lifestyle aspects which lead to an increased central nervous overactivity disturb significantly the metabolism and are critical risk factors for people with genetic predisposition relate to the pathogenesis of obesity. that might lead to high disability level associated comorbid states and high risk of cardiovascular events.